Focus on Pathways: Targeting the CSF-1R Pathway in Graft-vs-Host Disease - Episode 2

The CSF-1R Signaling Pathway in GVHD and Investigational Agents Targeting this Pathway

Dr. Choe discusses the potential role of the CSF-1R signaling pathway in the pathogenesis of numerous diseases, including GVHD. A video segment explores how dysregulation of this pathway can contribute to the development and progression of GVHD, providing the rationale for targeting CSF-1R as a potential therapeutic strategy.

EP. 1: Graft-Versus-Host Disease: Pathogenesis, Clinical Challenges, and Unmet Treatment Needs
Now Viewing
EP. 2: The CSF-1R Signaling Pathway in GVHD and Investigational Agents Targeting this Pathway
EP. 3: AGAVE-201 Investigating Axatilimab In Recurrent of Refractory cGVHD
EP. 4: Clinical Scenario and Perspectives on the Evolving Treatment Landscape in GVHD

Related Content:

Focus on Pathways: Targeting the CSF-1R Pathway in Graft-vs-Host DiseaseHematologic Oncology
NICE Advocates Reimbursement for Avapritinib in Aggressive Systemic Mastocytosis, Other Hematologic Malignancies
OncLive’s October Roundup of Key FDA Approvals in Oncology
The OncFive: Top Oncology Articles for the Week of 10/27